{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:39:44Z","timestamp":1753889984283,"version":"3.41.2"},"reference-count":145,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cardiovascular (CV) risk factors, particularly cardiometabolic, seem to be\nassociated with heightened severity and increased morbimortality in patients infected with the novel\nCoronavirus disease-2019 (COVID-19).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A thorough scoping review was conducted to elucidate and summarize the latest evidence\nfor the effects of adverse cardiac metabolic profiles on the severity, morbidity, and prognosis\nof COVID-19 infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The pathophysiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\nis complex, being characterized by viral-induced immune dysregulation and hypercytokinemia,\nparticularly in patients with critical disease, evolving with profound endothelial dysfunction, systemic\ninflammation, and prothrombotic state. Moreover, cardiovascular comorbidities such as diabetes\nare the most prevalent amongst individuals requiring hospitalization, raising concerns towards\nthe clinical evolution and prognosis of these patients. The chronic proinflammatory state observed\nin patients with cardiovascular risk factors may contribute to the immune dysregulation mediated\nby SARS-CoV-2, favoring more adverse clinical outcomes and increased severity. Cardiometabolism\nis defined as a combination of interrelated risk factors and metabolic dysfunctions\nsuch as dyslipidemia, insulin resistance, impaired glucose tolerance, and central adiposity, which\nincrease the likelihood of vascular events, being imperative to specifically analyze its clinical association\nwith COVID-19 outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>DM and obesity appears to be important risk factors for severe COVID-19. The\nchronic proinflammatory state observed in patients with excess visceral adipose tissue (VAT) possibly\naugments COVID-19 immune hyperactivity leading to more adverse clinical outcomes in these\npatients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573403x18666220509154236","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T13:06:04Z","timestamp":1652274364000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Metabolic Risk Factors on COVID-19 Clinical Outcomes: An\nExtensive Review"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3853-7842","authenticated-orcid":true,"given":"Elizabeth S.","family":"Muxfeldt","sequence":"first","affiliation":[{"name":"Medicine Course, IDOMED - Universidade Est\u00e1cio de S\u00e1 - Campus Presidente Vargas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6864-8805","authenticated-orcid":true,"given":"Rafael B.","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Medicine Course, IDOMED - Universidade Est\u00e1cio de S\u00e1 - Campus Presidente Vargas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0845-2621","authenticated-orcid":true,"given":"D\u00e9bora C.R.","family":"Wandermurem","sequence":"additional","affiliation":[{"name":"Medicine Course, IDOMED - Universidade Est\u00e1cio de S\u00e1 - Campus Presidente Vargas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-7614","authenticated-orcid":true,"given":"Fl\u00e1via C.F.","family":"Lib\u00f3rio","sequence":"additional","affiliation":[{"name":"Medicine Course, IDOMED - Universidade Est\u00e1cio de S\u00e1 - Campus Presidente Vargas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3346-7259","authenticated-orcid":true,"given":"Ma\u00edra K.","family":"Machado","sequence":"additional","affiliation":[{"name":"Medicine Course, IDOMED - Universidade Est\u00e1cio de S\u00e1 - Campus Presidente Vargas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-6443","authenticated-orcid":true,"given":"Nat\u00e1lia M.","family":"Ushijima","sequence":"additional","affiliation":[{"name":"Medicine Course, IDOMED - Universidade Est\u00e1cio de S\u00e1 - Campus Presidente Vargas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1980-3140","authenticated-orcid":true,"given":"Ramon S.","family":"Narde","sequence":"additional","affiliation":[{"name":"Medicine Course, IDOMED - Universidade Est\u00e1cio de S\u00e1 - Campus Presidente Vargas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1043-0907","authenticated-orcid":true,"given":"Inah Maria","family":"D. Pecly","sequence":"additional","affiliation":[{"name":"Medicine Course, IDOMED - Universidade Est\u00e1cio de S\u00e1 - Campus Presidente Vargas, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Li Q.","year":"2020","unstructured":"Li Q.; Guan X.; Wu P.; Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020,382(13),1199-1207","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2000058","DOI":"10.2807\/1560-7917.ES.2020.25.4.2000058","volume":"25","author":"Riou J.","year":"2020","unstructured":"Riou J.; Althaus C.L.; Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill 2020,25(4),2000058","journal-title":"Euro Surveill"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3201\/eid2605.200198","volume":"26","author":"Tong Z-D.","year":"2020","unstructured":"Tong Z-D.; Tang A.; Li K-F.; Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis 2020,26(5),1052-1054","journal-title":"Emerg Infect Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1056\/NEJMe2009758","volume":"382","author":"Gandhi M.","year":"2020","unstructured":"Gandhi M.; Yokoe D.S.; Havlir D.V.; Asymptomatic transmission, the achilles\u2019 heel of current strategies to control covid-19. N Engl J Med 2020,382(22),2158-2160","journal-title":"N Engl J Med"},{"journal-title":"Situation Report - 105 Coronavirus disease (COVID-19)","year":"2021","key":"ref=5","unstructured":"Situation Report - 105 Coronavirus disease (COVID-19) World Health OrganizationAvailable from:  [Accessed on Apr 18, 2022].2021"},{"journal-title":"WHO Coronavirus Disease (COVID-19) Dashboard World Health Organization","year":"2021","key":"ref=6","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard World Health Organization Available from:  Accessed on 15th February 2022.2021"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S2213-2600(21)00218-6","volume":"9","author":"Osuchowski M.F.","year":"2021","unstructured":"Osuchowski M.F.; Winkler M.S.; Skirecki T.; The COVID-19 puzzle: Deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021,9(6),622-642","journal-title":"Lancet Respir Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"Tay M.Z.","year":"2020","unstructured":"Tay M.Z.; Poh C.M.; R&#xE9;nia L.; MacAry P.A.; Ng L.F.P.; The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol 2020,20(6),363-374","journal-title":"Nat Rev Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41577-020-0305-6","volume":"20","author":"Vaninov N.","year":"2020","unstructured":"Vaninov N.; In the eye of the COVID-19 cytokine storm. Nat Rev Immunol 2020,20(5),277","journal-title":"Nat Rev Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","volume":"8","author":"Jose R.J.","year":"2020","unstructured":"Jose R.J.; Manuel A.; COVID-19 cytokine storm: The interplay between inflammation and coagulation. Lancet Respir Med 2020,8(6),e46-e47","journal-title":"Lancet Respir Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"Gupta A.","year":"2020","unstructured":"Gupta A.; Madhavan M.V.; Sehgal K.; Extrapulmonary manifestations of COVID-19. Nat Med 2020,26(7),1017-1032","journal-title":"Nat Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"Levi M.","year":"2020","unstructured":"Levi M.; Thachil J.; Iba T.; Levy J.H.; Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 2020,7(6),e438-e440","journal-title":"Lancet Haematol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","volume":"5","author":"Lindner D.","year":"2020","unstructured":"Lindner D.; Fitzek A.; Br&#xE4;uninger H.; Association of cardian infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol 2020,5(11),1281-1285","journal-title":"JAMA Cardiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Varga Z.","year":"2020","unstructured":"Varga Z.; Flammer A.J.; Steiger P.; Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020,395(10234),1417-1418","journal-title":"Lancet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","volume":"396","author":"Bradley B.T.","year":"2020","unstructured":"Bradley B.T.; Maioli H.; Johnston R.; Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: A case series. Lancet 2020,396(10247),320-332","journal-title":"Lancet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","volume":"41","author":"Libby P.","year":"2020","unstructured":"Libby P.; L&#xFC;scher T.; COVID-19 is, in the end, an endothelial disease. Eur Heart J 2020,41(32),3038-3044","journal-title":"Eur Heart J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e045482","DOI":"10.1136\/bmjopen-2020-045482","volume":"11","author":"Collard D.","year":"2021","unstructured":"Collard D.; Nurmohamed N.S.; Kaiser Y.; Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: A prospective cohort study. BMJ Open 2021,11(2),e045482","journal-title":"BMJ Open"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/heartjnl-2020-317901","volume":"107","author":"Bae S.","year":"2021","unstructured":"Bae S.; Kim S.R.; Kim M.N.; Shim W.J.; Park S.M.; Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: A systematic review and meta-analysis. Heart 2021,107(5),373-380","journal-title":"Heart"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1001\/jamainternmed.2020.3596","volume":"180","author":"Gupta S.","year":"2020","unstructured":"Gupta S.; Hayek S.S.; Wang W.; Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med 2020,180(11),1436-1447","journal-title":"JAMA Intern Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamainternmed.2020.5313","volume":"181","author":"Cunningham J.W.","year":"2020","unstructured":"Cunningham J.W.; Vaduganathan M.; Claggett B.L.; Clinical outcomes in young US adults hospitalized with COVID-19. JAMA Intern Med 2020,181(3),379-381","journal-title":"JAMA Intern Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ahj.2004.07.013","volume":"149","author":"Miranda P.J.","year":"2005","unstructured":"Miranda P.J.; DeFronzo R.A.; Califf R.M.; Guyton J.R.; Metabolic syndrome: Definition, pathophysiology, and mechanisms. Am Heart J 2005,149(1),33-45","journal-title":"Am Heart J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1753944717711379","volume":"11","author":"Rochlani Y.","year":"2017","unstructured":"Rochlani Y.; Pothineni N.V.; Kovelamudi S.; Mehta J.L.; Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis 2017,11(8),215-225","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"bqaa112","DOI":"10.1210\/endocr\/bqaa112","volume":"161","author":"Bansal R.","year":"2020","unstructured":"Bansal R.; Gubbi S.; Muniyappa R.; Metabolic syndrome and COVID-19: Endocrine-immune-vascular interactions shapes clinical course. Endocrinology 2020,161(10),bqaa112","journal-title":"Endocrinology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13098-021-00639-2","volume":"13","author":"Santos A.","year":"2021","unstructured":"Santos A.; Magro D.O.; Evangelista-Poderoso R.; Saad M.J.A.; Diabetes, obesity, and insulin resistance in COVID-19: Molecular interrelationship and therapeutic implications. Diabetol Metab Syndr 2021,13(1),23","journal-title":"Diabetol Metab Syndr"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41366-021-00804-7","volume":"45","author":"Batabyal R.","year":"2021","unstructured":"Batabyal R.; Freishtat N.; Hill E.; Rehman M.; Freishtat R.; Koutroulis I.; Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics. Int J Obes 2021,45(6),1163-1169","journal-title":"Int J Obes"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13098-019-0468-0","volume":"11","author":"Cercato C.","year":"2019","unstructured":"Cercato C.; Fonseca F.A.; Cardiovascular risk and obesity. Diabetol Metab Syndr 2019,11(11),74","journal-title":"Diabetol Metab Syndr"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41366-020-0648-x","volume":"44","author":"Nakeshbandi M.","year":"2020","unstructured":"Nakeshbandi M.; Maini R.; Daniel P.; The impact of obesity on COVID-19 complications: A retrospective cohort study. Int J Obes 2020,44(9),1832-1837","journal-title":"Int J Obes"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrcardio.2009.55","volume":"6","author":"Rocha V.Z.","year":"2009","unstructured":"Rocha V.Z.; Libby P.; Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009,6(6),399-409","journal-title":"Nat Rev Cardiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/oby.22831","volume":"28","author":"Simonnet A","year":"2020","unstructured":"Simonnet A; Chetboun M; Poissy J; High prevalence of obesity in severe acute respiratory syndromecCoronavirus-2 (SARSCoV-2) requiring mechanical ventilation. Obesity (Silver Spring) 2020,28(7),1195-1199","journal-title":"Obesity (Silver Spring)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"m1966","DOI":"10.1136\/bmj.m1966","volume":"369","author":"Petrilli C.M.","year":"2020","unstructured":"Petrilli C.M.; Jones S.A.; Yang J.; Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ 2020,369,m1966","journal-title":"BMJ"},{"year":"2021","key":"ref=32","unstructured":"Obesity-WHO| World Health Organization. World Health Organization (WHO). Available from:  Accessed on 24th May 2021. [Accessed on Apr 18, 2022].2021"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/oby.22923","volume":"28","author":"Hajifathalian K.","year":"2020","unstructured":"Hajifathalian K.; Kumar S.; Newberry C.; Obesity is associated with worse outcomes in COVID-19: Analysis of early data from New York City. Obesity (Silver Spring) 2020,28(9),1606-1612","journal-title":"Obesity (Silver Spring)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S2213-8587(20)30160-1","volume":"8","author":"Caussy C.","year":"2020","unstructured":"Caussy C.; Pattou F.; Wallet F.; Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol 2020,8(7),562-564","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.120.047659","volume":"142","author":"Sattar N.","year":"2020","unstructured":"Sattar N.; McInnes I.B.; McMurray J.J.V.; Obesity is a risk factor for severe COVID-19 infection: Multiple potential mechanisms. Circulation 2020,142(1),4-6","journal-title":"Circulation"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"154262","DOI":"10.1016\/j.metabol.2020.154262","volume":"108","author":"Palaiodimos L.","year":"2020","unstructured":"Palaiodimos L.; Kokkinidis D.G.; Li W.; Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism 2020,108,154262","journal-title":"Metabolism"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/dc20-0576","volume":"43","author":"Cai Q.","year":"2020","unstructured":"Cai Q.; Chen F.; Wang T.; Obesity and COVID-19 severity in a designated hospital in Shenzen, China. Diabetes Care 2020,43(7),1392-1398","journal-title":"Diabetes Care"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/oby.22979","volume":"28","author":"Wang J.","year":"2020","unstructured":"Wang J.; Zhu L.; Liu L.; Overweight and obesity are risk factors of severe illness in patients with COVID-19. Obesity (Silver Spring) 2020,28(11),2049-2055","journal-title":"Obesity (Silver Spring)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/dom.14194","volume":"23","author":"Luo X.","year":"2021","unstructured":"Luo X.; Jiaerken Y.; Shen Z.; Obese COVID-19 patients show more severe pneumonia lesions on CT chest imaging. Diabetes Obes Metab 2021,23(1),290-293","journal-title":"Diabetes Obes Metab"},{"journal-title":"Centers for Disease Control and Prevention","year":"2021","key":"ref=40","unstructured":"Centers for Disease Control and Prevention CDC"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/S0140-6736(20)31024-2","volume":"395","author":"Kass D.A.","year":"2020","unstructured":"Kass D.A.; Duggal P.; Cingolani O.; Obesity could shift severe COVID-19 disease to younger ages. Lancet 2020,395(10236),1544-1545","journal-title":"Lancet"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/oby.22913","volume":"28","author":"Klang E.","year":"2020","unstructured":"Klang E.; Kassim G.; Soffer S.; Freeman R.; Levin M.A.; Reich D.L.; Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50. Obesity (Silver Spring) 2020,28(9),1595-1599","journal-title":"Obesity (Silver Spring)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/cid\/ciaa415","volume":"71","author":"Lighter J.","year":"2020","unstructured":"Lighter J.; Phillips M.; Hochman S.; Obesity in patients younger than 60 Years is a risk factor for COVD-19 hospital admission. Clin Infect Dis 2020,71(15),896-897","journal-title":"Clin Infect Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41366-021-00771-z","volume":"45","author":"Yates T.","year":"2021","unstructured":"Yates T.; Razieh C.; Zaccardi F.; Obesity, walking pace and risk of severe COVID-19 and mortality: Analysis of UK Biobank. Int J Obes 2021,45(5),1155-1159","journal-title":"Int J Obes"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.2337\/dc20-0682","volume":"43","author":"Gao F.","year":"2020","unstructured":"Gao F.; Zheng K.I.; Wang X-B.; Obesity is a risk factor for greater COVID-19 severity. Diabetes Care 2020,43(7),e72-e74","journal-title":"Diabetes Care"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"Despr&#xE9;s J.P.","year":"2012","unstructured":"Despr&#xE9;s J.P.; Body fat distribution and risk of cardiovascular disease: An update. Circulation 2012,126(10),1301-1313","journal-title":"Circulation"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejim.2017.10.020","volume":"48","author":"Vecchi&#xE9; A.","year":"2018","unstructured":"Vecchi&#xE9; A.; Dallegri F.; Carbone F.; Obesity phenotypes and their paradoxical association with cardiovascular diseases. Eur J Intern Med 2018,48,6-17","journal-title":"Eur J Intern Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.2337\/dcS13-2023","volume":"36","author":"Hainer V.","year":"2013","unstructured":"Hainer V.; Aldhoon-Hainerov&#xE1; I.; Obesity paradox does exist. Diabetes Care 2013,36(2)(Suppl. 2),S276-S281","journal-title":"Diabetes Care"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/archinte.165.1.55","volume":"165","author":"Curtis J.P.","year":"2005","unstructured":"Curtis J.P.; Selter J.G.; Wang Y.; The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch Intern Med 2005,165(1),55-61","journal-title":"Arch Intern Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","volume":"126","author":"Pich&#xE9; M-E.","year":"2020","unstructured":"Pich&#xE9; M-E.; Tchernof A.; Despr&#xE9;s J-P.; Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res 2020,126(11),1477-1500","journal-title":"Circ Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/nutrit\/nuu007","volume":"73","author":"Teixeira T.F.S.","year":"2015","unstructured":"Teixeira T.F.S.; Alves R.D.M.; Moreira A.P.B.; Peluzio M.C.; Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes. Nutr Rev 2015,73(3),175-190","journal-title":"Nutr Rev"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13105-020-00781-x","volume":"77","author":"G&#xF3;mez-Zorita S.","year":"2021","unstructured":"G&#xF3;mez-Zorita S.; Queralt M.; Vicente M.A.; Gonz&#xE1;lez M.; Portillo M.P.; Metabolically healthy obesity and metabolically obese normal weight: A review. J Physiol Biochem 2021,77(1),175-189","journal-title":"J Physiol Biochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1161\/CIR.0b013e318233bc6a","volume":"124","author":"Cornier M.A.","year":"2011","unstructured":"Cornier M.A.; Despr&#xE9;s J.P.; Davis N.; Assessing adiposity: A scientific statement from the American Heart Association. Circulation 2011,124(18),1996-2019","journal-title":"Circulation"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"12699","DOI":"10.1038\/s41598-020-69498-7","volume":"10","author":"Sommer I.","year":"2020","unstructured":"Sommer I.; Teufer B.; Szelag M.; The performance of anthropometric tools to determine obesity: A systematic review and meta-analysis. Sci Rep 2020,10(1),12699","journal-title":"Sci Rep"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/sj.ijo.0802695","volume":"28","author":"Onat A.","year":"2004","unstructured":"Onat A.; Avci G.S.; Barlan M.M.; Uyarel H.; Uzunlar B.; Sansoy V.; Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes 2004,28(8),1018-1025","journal-title":"Int J Obes"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"154317","DOI":"10.1016\/j.metabol.2020.154317","volume":"110","author":"Petersen A.","year":"2020","unstructured":"Petersen A.; Bressem K.; Albrecht J.; The role of visceral adiposity in the severity of COVID-19: Highlights from a uni-center cross-sectional pilot study in Germany. Metabolism 2020,110,154317","journal-title":"Metabolism"},{"key":"ref=57","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-021-01173-w","author":"Malavazos A.E.","year":"2021","unstructured":"Malavazos A.E.; Secchi F.; Basilico S.; Abdominal obesity phenotype is associated with COVID-19 chest X-ray severity score better than BMI-based obesity. Eat Weight Disord 2021","journal-title":"Eat Weight Disord"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/oby.22971","volume":"28","author":"Yang Y.","year":"2020","unstructured":"Yang Y.; Ding L.; Zou X.; Visceral adiposity and high intramuscular fat deposition independently predict critical illness in patients with SARS-CoV-2. Obesity (Silver Spring) 2020,28(11),2040-2048","journal-title":"Obesity (Silver Spring)"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"787","DOI":"10.5935\/abc.20190204","volume":"113","author":"Pr&#xE9;coma D.B.","year":"2019","unstructured":"Pr&#xE9;coma D.B.; Oliveira G.M.M.; Sim&#xE3;o A.F.; Atualiza&#xE7;&#xE3;o da Diretriz de Preven&#xE7;&#xE3;o Cardiovascular da Sociedade Brasileira de Cardiologia \u2013 2019. Arq Bras Cardiol 2019,113(4),787-891","journal-title":"Arq Bras Cardiol"},{"journal-title":"The IDF consensus world-wide definition of the metabolic syndrome","year":"2006","key":"ref=60","unstructured":"The IDF consensus world-wide definition of the metabolic syndrome International Diabetes FederationAvailable from:  [Accessed on 24th May 2021].2006"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2337\/db06-1656","volume":"56","author":"Fontana L.","year":"2007","unstructured":"Fontana L.; Eagon J.C.; Trujillo M.E.; Scherer P.E.; Klein S.; Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007,56(4),1010-1013","journal-title":"Diabetes"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.atherosclerosis.2013.12.023","volume":"233","author":"Alexopoulos N.","year":"2014","unstructured":"Alexopoulos N.; Katritsis D.; Raggi P.; Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis 2014,233(1),104-112","journal-title":"Atherosclerosis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/er.2008-0024","volume":"29","author":"Cornier M-A.","year":"2008","unstructured":"Cornier M-A.; Dabelea D.; Hernandez T.L.; The metabolic syndrome. Endocr Rev 2008,29(7),777-822","journal-title":"Endocr Rev"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1161\/ATVBAHA.111.241869","volume":"32","author":"Romeo G.R.","year":"2012","unstructured":"Romeo G.R.; Lee J.; Shoelson S.E.; Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol 2012,32(8),1771-1776","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jvs.2011.01.003","volume":"54","author":"Vykoukal D.","year":"2011","unstructured":"Vykoukal D.; Davies M.G.; Vascular biology of metabolic syndrome. J Vasc Surg 2011,54(3),819-831","journal-title":"J Vasc Surg"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"829","DOI":"10.36660\/abc.20200308","volume":"114","author":"Nascimento J.H.P.","year":"2020","unstructured":"Nascimento J.H.P.; Gomes B.F.O.; Carmo J&#xFA;nior P.R.D.; COVID-19 and hypercoagulable state: A new therapeutic perspective. Arq Bras Cardiol 2020,114(5),829-833","journal-title":"Arq Bras Cardiol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","volume":"122","author":"Samad F.","year":"2013","unstructured":"Samad F.; Ruf W.; Inflammation, obesity, and thrombosis. Blood 2013,122(20),3415-3422","journal-title":"Blood"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.metop.2020.100057","volume":"8","author":"Ghoneim S.","year":"2020","unstructured":"Ghoneim S.; Butt M.U.; Hamid O.; Shah A.; Asaad I.; The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study. Metabol Open 2020,8,100057","journal-title":"Metabol Open"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"dc201714","DOI":"10.2337\/dc20-1714","author":"Xie J.","year":"2020","unstructured":"Xie J.; Zu Y.; Alkhatib A.; Metabolic syndrome and COVID-19 mortality among adult black patients in New Orleans. Diabetes Care 2020,dc201714","journal-title":"Diabetes Care"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5334\/gh.814","volume":"15","author":"Matsushita K.","year":"2020","unstructured":"Matsushita K.; Ding N.; Kou M.; The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-Analysis. Glob Heart 2020,15(1),64","journal-title":"Glob Heart"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","volume":"5","author":"Madjid M.","year":"2020","unstructured":"Madjid M.; Safavi-Naeini P.; Solomon S.D.; Vardeny O.; Potential effects of coronaviruses on the cardiovascular system. JAMA Cardiol 2020,5(7),831-840","journal-title":"JAMA Cardiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","volume":"141","author":"Clerkin K.J.","year":"2020","unstructured":"Clerkin K.J.; Fried J.A.; Raikhelkar J.; COVID-19 and cardiovascular disease. Circulation 2020,141(20),1648-1655","journal-title":"Circulation"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","volume":"17","author":"Zheng Y-Y.","year":"2020","unstructured":"Zheng Y-Y.; Ma Y-T.; Zhang J-Y.; Xie X.; COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020,17(5),259-260","journal-title":"Nat Rev Cardiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","volume":"75","author":"Driggin E.","year":"2020","unstructured":"Driggin E.; Madhavan M.V.; Bikdeli B.; Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020,75(18),2352-2371","journal-title":"J Am Coll Cardiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","volume":"5","author":"Shi S.","year":"2020","unstructured":"Shi S.; Qin M.; Shen B.; Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020,5(7),802-810","journal-title":"JAMA Cardiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"Wang D.","year":"2020","unstructured":"Wang D.; Hu B.; Hu C.; Clinical characteristics of 138 hospitalized patients With 2019 Novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020,323(11),1061-1069","journal-title":"JAMA"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"855","DOI":"10.7326\/M20-2730","volume":"173","author":"Goyal P.","year":"2020","unstructured":"Goyal P.; Ringel J.B.; Rajan M.; Obesity and COVID-19 in New York City: A retrospective cohort study. Ann Intern Med 2020,173(10),855-858","journal-title":"Ann Intern Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"154378","DOI":"10.1016\/j.metabol.2020.154378","volume":"113","author":"Huang Y.","year":"2020","unstructured":"Huang Y.; Lu Y.; Huang Y.M.; Obesity in patients with COVID-19: A systematic review and meta-analysis. Metabolism 2020,113,154378","journal-title":"Metabolism"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ecl.2004.03.008","volume":"33","author":"Devaraj S.","year":"2004","unstructured":"Devaraj S.; Rosenson R.S.; Jialal I.; Metabolic syndrome: An appraisal of the pro-inflammatory and procoagulant status. Endocrinol Metab Clin North Am 2004,33(2),431-453","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"108142","DOI":"10.1016\/j.diabres.2020.108142","volume":"162","author":"Hussain A.","year":"2020","unstructured":"Hussain A.; Bhowmik B.; do Vale Moreira N.C.; COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract 2020,162,108142","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12879-021-05915-0","volume":"21","author":"Yin T.","year":"2021","unstructured":"Yin T.; Li Y.; Ying Y.; Luo Z.; Prevalence of comorbidity in Chinese patients with COVID-19: Systematic review and meta-analysis of risk factors. BMC Infect Dis 2021,21(1),200","journal-title":"BMC Infect Dis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/ijms18030563","volume":"18","author":"Roca-Ho H.","year":"2017","unstructured":"Roca-Ho H.; Riera M.; Palau V.; Pascual J.; Soler M.J.; Characterization of ACE and ACE2 expression within different organs of the NOD mouse. Int J Mol Sci 2017,18(3),563","journal-title":"Int J Mol Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","volume":"14","author":"Singh A.K.","year":"2020","unstructured":"Singh A.K.; Gupta R.; Ghosh A.; Misra A.; Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 2020,14(4),303-310","journal-title":"Diabetes Metab Syndr"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"m1091","DOI":"10.1136\/bmj.m1091","volume":"368","author":"Chen T.","year":"2020","unstructured":"Chen T.; Wu D.; Chen H.; Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ 2020,368,m1091","journal-title":"BMJ"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"e001343","DOI":"10.1136\/bmjdrc-2020-001343","volume":"8","author":"Yan Y.","year":"2020","unstructured":"Yan Y.; Yang Y.; Wang F.; Clinical Characteristics and outcomes of patients with severe Covid-19 with diabetes. BMJ Open Diabetes Res Care 2020,8(1),e001343","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","volume":"14","author":"Huang I.","year":"2020","unstructured":"Huang I.; Lim M.A.; Pranata R.; Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020,14(4),395-403","journal-title":"Diabetes Metab Syndr"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"104354","DOI":"10.1016\/j.jcv.2020.104354","volume":"127","author":"Roncon L.","year":"2020","unstructured":"Roncon L.; Zuin M.; Rigatelli G.; Zuliani G.; Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol 2020,127,104354","journal-title":"J Clin Virol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"Li B.","year":"2020","unstructured":"Li B.; Yang J.; Zhao F.; Prevalence and impact of cardio-vascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020,109(5),531-538","journal-title":"Clin Res Cardiol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"108263","DOI":"10.1016\/j.diabres.2020.108263","volume":"165","author":"Alkundi A.","year":"2020","unstructured":"Alkundi A.; Mahmoud I.; Musa A.; Naveed S.; Alshawwaf M.; Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study. Diabetes Res Clin Pract 2020,165,108263","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1177\/1932296820924469","volume":"14","author":"Bode B.","year":"2020","unstructured":"Bode B.; Garrett V.; Messler J.; Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 2020,14(4),813-821","journal-title":"J Diabetes Sci Technol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2188\/jea.JE20190091","volume":"30","author":"Wang M.","year":"2020","unstructured":"Wang M.; Muraki I.; Liu K.; Diabetes and mortality from respiratory diseases: The Japan collaborative cohort study. J Epidemiol 2020,30(10),457-463","journal-title":"J Epidemiol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2337\/dc09-2215","volume":"33","author":"Allard R.","year":"2010","unstructured":"Allard R.; Leclerc P.; Tremblay C.; Tannenbaum T.N.; Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 2010,33(7),1491-1493","journal-title":"Diabetes Care"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","volume":"17","author":"Lim S.","year":"2021","unstructured":"Lim S.; Bae J.H.; Kwon H.S.; Nauck M.A.; COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat Rev Endocrinol 2021,17(1),11-30","journal-title":"Nat Rev Endocrinol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"Richardson S.","year":"2020","unstructured":"Richardson S.; Hirsch J.S.; Narasimhan M.; Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA 2020,323(20),2052-2059","journal-title":"JAMA"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","volume":"55","author":"Guan W.J.","year":"2020","unstructured":"Guan W.J.; Liang W.H.; Zhao Y.; Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J 2020,55(5),2000547","journal-title":"Eur Respir J"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","volume":"14","author":"Kumar A.","year":"2020","unstructured":"Kumar A.; Arora A.; Sharma P.; Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr 2020,14(4),535-545","journal-title":"Diabetes Metab Syndr"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"Zhou F.","year":"2020","unstructured":"Zhou F.; Yu T.; Du R.; Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020,395(10229),1054-1062","journal-title":"Lancet"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"Williamson E.J.","year":"2020","unstructured":"Williamson E.J.; Walker A.J.; Bhaskaran K.; Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020,584(7821),430-436","journal-title":"Nature"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","volume":"63","author":"Cariou B.","year":"2020","unstructured":"Cariou B.; Hadjadj S.; Wargny M.; Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: The CORONADO study. Diabetologia 2020,63(8),1500-1515","journal-title":"Diabetologia"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","volume":"8","author":"Apicella M.","year":"2020","unstructured":"Apicella M.; Campopiano M.C.; Mantuano M.; Mazoni L.; Coppelli A.; Del Prato S.; COVID-19 in people with diabetes: Understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 2020,8(9),782-792","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1096\/fj.202001451","volume":"34","author":"Sorokin A.V.","year":"2020","unstructured":"Sorokin A.V.; Karathanasis S.K.; Yang Z.H.; Freeman L.; Kotani K.; Remaley A.T.; COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J 2020,34(8),9843-9853","journal-title":"FASEB J"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"E197","DOI":"10.1152\/ajpendo.00255.2020","volume":"319","author":"Cao X.","year":"2020","unstructured":"Cao X.; Yin R.; Albrecht H.; Fan D.; Tan W.; Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2? Am J Physiol Endocrinol Metab 2020,319(1),E197-E202","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.dsx.2020.07.054","volume":"14","author":"Hariyanto T.I.","year":"2020","unstructured":"Hariyanto T.I.; Kurniawan A.; Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr 2020,14(5),1463-1465","journal-title":"Diabetes Metab Syndr"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","volume":"180","author":"Grasselli G.","year":"2020","unstructured":"Grasselli G.; Greco M.; Zanella A.; Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 2020,180(10),1345-1355","journal-title":"JAMA Intern Med"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/joim.13070","volume":"287","author":"Vuorio A.","year":"2020","unstructured":"Vuorio A.; Watts G.F.; Kovanen P.T.; Familial hypercholesterolaemia and COVID-19: Triggering of increased sustained cardiovascular risk. J Intern Med 2020,287(6),746-747","journal-title":"J Intern Med"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cca.2020.07.015","volume":"510","author":"Hu X.","year":"2020","unstructured":"Hu X.; Chen D.; Wu L.; He G.; Ye W.; Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta 2020,510,105-110","journal-title":"Clin Chim Acta"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","volume":"14","author":"Wei X.","year":"2020","unstructured":"Wei X.; Zeng W.; Su J.; Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol 2020,14(3),297-304","journal-title":"J Clin Lipidol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"154243","DOI":"10.1016\/j.metabol.2020.154243","volume":"107","author":"Fan J.","year":"2020","unstructured":"Fan J.; Wang H.; Ye G.; Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism 2020,107,154243","journal-title":"Metabolism"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/138161212799504803","volume":"18","author":"Antonopoulos A.S.","year":"2012","unstructured":"Antonopoulos A.S.; Margaritis M.; Lee R.; Channon K.; Antoniades C.; Statins as anti-inflammatory agents in atherogenesis: Molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des 2012,18(11),1519-1530","journal-title":"Curr Pharm Des"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1161\/01.CIR.0000033635.42612.88","volume":"106","author":"Lefer D.J.","year":"2002","unstructured":"Lefer D.J.; Statins as potent antiinflammatory drugs. Circulation 2002,106(16),2041-2042","journal-title":"Circulation"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.dsx.2020.08.023","volume":"14","author":"Hariyanto T.I.","year":"2020","unstructured":"Hariyanto T.I.; Kurniawan A.; Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr 2020,14(6),1613-1615","journal-title":"Diabetes Metab Syndr"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","volume":"32","author":"Zhang X.J.","year":"2020","unstructured":"Zhang X.J.; Qin J.J.; Cheng X.; In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab 2020,32(2),176-187.e4","journal-title":"Cell Metab"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.amjcard.2020.09.012","volume":"136","author":"Daniels L.B.","year":"2020","unstructured":"Daniels L.B.; Sitapati A.M.; Zhang J.; Relation of statin use prior to admission to severity and recovery Among COVID-19 inpatients. Am J Cardiol 2020,136,149-155","journal-title":"Am J Cardiol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(94)90566-5","volume":"344","year":"1994","unstructured":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet Scandinavian Simvastatin Survival Study Group1994,344(8934),1383-1389","journal-title":"Lancet"},{"key":"ref=115","first-page":"10001","volume":"225","author":"Sacks F.M.","year":"1996","unstructured":"Sacks F.M.; Pfeffer M.A.; Moye L.A.; Rouleau J.L.; Rutherford J.D.; Cole T.G.; The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996,225,10001-10009","journal-title":"N Engl J Med"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","volume":"105","author":"Heeschen C.","year":"2002","unstructured":"Heeschen C.; Hamm C.W.; Laufs U.; Snapinn S.; B&#xF6;hm M.; White H.D.; Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002,105(12),1446-1452","journal-title":"Circulation"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/ehjcvp\/pvaa042","volume":"6","author":"Castiglione V.","year":"2020","unstructured":"Castiglione V.; Chiriac&#xF2; M.; Emdin M.; Taddei S.; Vergaro G.; Statin therapy in COVID-19 infection. Eur Heart J Cardiovasc Pharmacother 2020,6(4),258-259","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ijid.2020.05.115","volume":"96","author":"Lee K.C.H.","year":"2020","unstructured":"Lee K.C.H.; Sewa D.W.; Phua G.C.; Potential role of statins in COVID-19. Int J Infect Dis 2020,96,615-617","journal-title":"Int J Infect Dis"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.dsx.2020.07.011","volume":"14","author":"Subir R.","year":"2020","unstructured":"Subir R.; Jagat J.M.; Kalyan K.G.; Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19). Diabetes Metab Syndr 2020,14(5),1225-1229","journal-title":"Diabetes Metab Syndr"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.atherosclerosis.2020.09.008","volume":"313","author":"Iqbal Z.","year":"2020","unstructured":"Iqbal Z.; Ho J.H.; Adam S.; Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis 2020,313,126-136","journal-title":"Atherosclerosis"},{"journal-title":"ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic","year":"2020","key":"ref=121","unstructured":"ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic European Society of CardiologyAvailable from:  [Accessed on Apr 18, 2022].2020"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"110452","DOI":"10.1016\/j.mehy.2020.110452","volume":"146","author":"Barkas F.","year":"2021","unstructured":"Barkas F.; Milionis H.; Anastasiou G.; Liberopoulos E.; Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019? Med Hypotheses 2021,146,110452","journal-title":"Med Hypotheses"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.numecd.2020.05.003","volume":"30","author":"Scicali R.","year":"2020","unstructured":"Scicali R.; Di Pino A.; Piro S.; Rabuazzo A.M.; Purrello F.; May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects? Nutr Metab Cardiovasc Dis 2020,30(7),1068-1069","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.sleep.2009.10.005","volume":"11","author":"Tufik S.","year":"2010","unstructured":"Tufik S.; Santos-Silva R.; Taddei J.A.; Bittencourt L.R.A.; Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 2010,11(5),441-446","journal-title":"Sleep Med"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.5664\/jcsm.8596","volume":"16","author":"Tufik S.","year":"2020","unstructured":"Tufik S.; Gozal D.; Ishikura I.A.; Pires G.N.; Andersen M.L.; Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity? J Clin Sleep Med 2020,16(8),1425-1426","journal-title":"J Clin Sleep Med"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.5664\/jcsm.8538","volume":"16","author":"McSharry D.","year":"2020","unstructured":"McSharry D.; Malhotra A.; Potential influences of obstructive sleep apnea and obesity on COVID-19 severity. J Clin Sleep Med 2020,16(9),1645","journal-title":"J Clin Sleep Med"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.5664\/jcsm.9214","volume":"17","author":"Roche J.","year":"2021","unstructured":"Roche J.; Rae D.E.; Redman K.N.; Impact of obstructive sleep apnea on cardiometabolic health in a random sample of older adults in rural South Africa: Building the case for the treatment of sleep disorders in underresourced settings. J Clin Sleep Med 2021,17(7),1423-1434","journal-title":"J Clin Sleep Med"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacc.2013.05.045","volume":"62","author":"Drager L.F.","year":"2013","unstructured":"Drager L.F.; Togeiro S.M.; Polotsky V.Y.; Lorenzi-Filho G.; Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol 2013,62(7),569-576","journal-title":"J Am Coll Cardiol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5935\/19840063.20200064","volume":"13","author":"Tufik S.","year":"2020","unstructured":"Tufik S.; Obstructive sleep apnea as a comorbidity to Covid-19. Sleep Sci 2020,13(3),181-182","journal-title":"Sleep Sci"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1513\/pats.200707-114MG","volume":"5","author":"Eckert D.J.","year":"2008","unstructured":"Eckert D.J.; Malhotra A.; Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008,5(2),144-153","journal-title":"Proc Am Thorac Soc"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1161\/CIRCRESAHA.118.310783","volume":"122","author":"Floras J.S.","year":"2018","unstructured":"Floras J.S.; Sleep Apnea and cardiovascular disease- An enigmatic risk factor. Circ Res 2018,122(12),1741-1764","journal-title":"Circ Res"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","volume":"46","author":"Gattinoni L.","year":"2020","unstructured":"Gattinoni L.; Chiumello D.; Caironi P.; COVID-19 pneumonia: Different respiratory treatments for different phenotypes? Intensive Care Med 2020,46(6),1099-1102","journal-title":"Intensive Care Med"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/jama.2020.4326","volume":"323","author":"Arentz M.","year":"2020","unstructured":"Arentz M.; Yim E.; Klaff L.; Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020,323(16),1612-1614","journal-title":"JAMA"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.sleep.2021.03.029","volume":"82","author":"Hariyanto T.I.","year":"2021","unstructured":"Hariyanto T.I.; Kurniawan A.; Obstructive Sleep Apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis. Sleep Med 2021,82,47-53","journal-title":"Sleep Med"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2147\/IJGM.S305295","volume":"14","author":"Halalau A.","year":"2021","unstructured":"Halalau A.; Odish F.; Imam Z.; Epidemiology, clinical characteristics, and outcomes of a large cohort of COVID-19 outpatients in Michigan. Int J Gen Med 2021,14,1555-1563","journal-title":"Int J Gen Med"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11325-020-02203-0","author":"Maas M.B.","year":"2020","unstructured":"Maas M.B.; Kim M.; Malkani R.G.; Abbott M.S.; Zee P.C.; Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. Sleep Breath 2020,1-3","journal-title":"Sleep Breath"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"e000845","DOI":"10.1136\/bmjresp-2020-000845","volume":"8","author":"Strausz S.","year":"2021","unstructured":"Strausz S.; Kiiskinen T.; Broberg M.; Sleep apnoea is a risk factor for severe COVID-19. BMJ Open Respir Res 2021,8(1),e000845","journal-title":"BMJ Open Respir Res"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.5664\/jcsm.9424","volume":"17","author":"Mashaqi S.","year":"2021","unstructured":"Mashaqi S.; Lee-Iannotti J.; Rangan P.; Obstructive sleep apnea and COVID-19 clinical outcomes during hospitalization: A cohort study. J Clin Sleep Med 2021,17(11),2197-2204","journal-title":"J Clin Sleep Med"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"106639","DOI":"10.1016\/j.clineuro.2021.106639","volume":"205","author":"Del Brutto O.H.","year":"2021","unstructured":"Del Brutto O.H.; Mera R.M.; Castillo P.R.; Recalde B.Y.; Costa A.F.; Previously diagnosed obstructive sleep apnea is not associated with increased risk of SARS-CoV-2 infection in community-dwelling older adults living in a highly endemic setting. Clin Neurol Neurosurg 2021,205,106639","journal-title":"Clin Neurol Neurosurg"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s11325-021-02373-5","volume":"25","author":"Chung F.","year":"2021","unstructured":"Chung F.; Waseem R.; Pham C.; The association between high risk of sleep apnea, comorbidities, and risk of COVID-19: A population-based international harmonized study. Sleep Breath 2021,25(2),849-860","journal-title":"Sleep Breath"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s41782-021-00142-8","volume":"5","author":"Kar A.","year":"2021","unstructured":"Kar A.; Saxena K.; Goyal A.; Assessment of obstructive sleep apnea in association with severity of COVID-19: A prospective observational study. Sleep Vigil 2021,5(1),111-118","journal-title":"Sleep Vigil"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1016\/j.bja.2020.04.078","volume":"125","author":"Memtsoudis S.G.","year":"2020","unstructured":"Memtsoudis S.G.; Ivascu N.S.; Pryor K.O.; Goldstein P.A.; Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: The potential role of undiagnosed obstructive sleep apnoea. Br J Anaesth 2020,125(2),e262-e263","journal-title":"Br J Anaesth"},{"journal-title":"Guidance regarding coronavirus (COVID-19) and obstructive sleep apnea (OSA): For people who routinely use continuous positive airway pressure (CPAP), their families and health care workers","key":"ref=143","unstructured":"Guidance regarding coronavirus (COVID-19) and obstructive sleep apnea (OSA): For people who routinely use continuous positive airway pressure (CPAP), their families and health care workers British Thoracic Society16 December 2020. 2020. Available from:  [Accessed on Apr 18, 2022]."},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.anorl.2020.05.001","volume":"137","author":"Bastier P.L.","year":"2020","unstructured":"Bastier P.L.; Aisenberg N.; Durand F.; Treatment of sleep apnea by ENT specialists during the COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis 2020,137(4),319-321","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"2001323","DOI":"10.1183\/13993003.01323-2020","volume":"55","author":"Grote L.","year":"2020","unstructured":"Grote L.; McNicholas W.T.; Hedner J.; Sleep apnoea management in Europe during the COVID-19 pandemic: Data from the European Sleep Apnoea Database (ESADA). Eur Respir J 2020,55(6),2001323","journal-title":"Eur Respir J"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573403X18666220509154236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204452\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573403X18666220509154236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T06:37:00Z","timestamp":1672036620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204452\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":145,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573403x18666220509154236","relation":{},"ISSN":["1573-403X"],"issn-type":[{"type":"print","value":"1573-403X"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e090522204452"}}